Log in to save to my catalogue

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9249628

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

About this item

Full title

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2022-07, Vol.41 (27), p.3511-3523

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Merkel cell carcinoma (MCC) is an aggressive malignancy with neuroendocrine (NE) features, limited treatment options, and a lack of druggable targets. There is no reported involvement of the MUC1-C oncogenic protein in MCC progression. We show here that MUC1-C is broadly expressed in MCCs and at higher levels in Merkel cell polyomavirus (MCPyV)-pos...

Alternative Titles

Full title

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9249628

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9249628

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-022-02361-3

How to access this item